NCT05639374 is a NA clinical trial of BASICS_HealthyClassroom in Alcohol Drinking, sponsored by Clinica Universidad de Navarra, Universidad de Navarra.

Who is sponsoring NCT05639374?

NCT05639374 is sponsored by Clinica Universidad de Navarra, Universidad de Navarra.

What drugs are being tested in NCT05639374?

Interventions in NCT05639374: BASICS_HealthyClassroom.

What condition does NCT05639374 study?

NCT05639374 studies Alcohol Drinking.

Is NCT05639374 still recruiting?

NCT05639374 is currently completed. Last updated 21 August 2023.

Last reviewed 2023-08-21 · How we verify

NCT05639374

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effectiveness of a Peer-led Program to Prevent Alcohol Consumption.

Completed NA Last updated 21 August 2023

What this trial tests

NA trial testing BASICS_HealthyClassroom in Alcohol Drinking in 308 participants. Completed in 31 July 2023.

Timeline

1 November 2022

Primary endpoint
30 June 2023

31 July 2023

Quick facts

Lead sponsor	Clinica Universidad de Navarra, Universidad de Navarra
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	prevention
Enrollment	308
Start date	1 November 2022
Primary completion	30 June 2023
Estimated completion	31 July 2023
Sites	1 location across Spain

Drugs / interventions tested

BASICS_HealthyClassroom

Conditions studied

Alcohol Drinking — all drugs for Alcohol Drinking →

Sponsor

Clinica Universidad de Navarra, Universidad de Navarra

Who can join

Adults 18 to 22, any sex, with Alcohol Drinking. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this Randomized clinical trial is to evaluate the effectiveness of a peer-led intervention to prevent alcohol consumption in university students. The main questions it aims to answer are: * Does a peer-led brief motivational intervention reduce the quantity and frequency of alcohol consumption among university students? * Does a peer-led brief motivational intervention reduce the negative consequences experienced by university students due to alcohol consumption? Participants will: * Complete a baseline online questionnaire (before the intervention) and one month after receiving the intervention. * Participants in the intervention group will receive a brief motivational intervention. Researchers will compare intervention and control group to see if there are statistically significant differences in relation to alcohol consumption.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Peer-led BASICS intervention to reduce alcohol consumption and alcohol-related consequences among university students: a randomized controlled trial.
Lavilla-Gracia M, Pueyo-Garrigues M, Calavia Gil D, Esandi-Larramendi N, et al · · 2023 · cited 2× · PMID 38026297 · DOI 10.3389/fpubh.2023.1280840

Verify or expand the search:

Other recruiting trials for Alcohol Drinking

Currently open trials in the same condition.

NCT07415707 — The GLUCID Study: Effect of Alcohol Reduction and Probiotic Interventions on Cognition and Brain Glucose Metabolism in N · NA · recruiting
NCT06815237 — Effects of Ketone Supplement and Alcohol on Brain Metabolism · Phase 2, PHASE3 · recruiting
NCT06994962 — Multi-Component Breath Alcohol Intervention Phase 3 · NA · recruiting
NCT05363878 — Development of a Culturally Grounded, Trauma-Informed Alcohol Intervention With a Reserve-Dwelling First Nation Group · NA · recruiting
NCT06309134 — The Healthy Families Bright Futures Program · NA · recruiting

Other Clinica Universidad de Navarra, Universidad de Navarra trials

Trials by the same sponsor.

NCT07370571 — NO AXILLARY SURGERY IN EARLY BREAST CANCER (OXIGENATE) · not yet recruiting
NCT07165431 — Effect of a Postbiotic Supplementation in Overweight and Obese Subjects: A Randomized Controlled Trial (PARABIOTICS-2). · NA · recruiting
NCT07447440 — Role of Pro-Resolving Lipid Mediators in Obesity-Associated Diseases · recruiting
NCT07191210 — Co-Designed Comprehensive Transition Programme for First-Line Nurse Managers · NA · not yet recruiting
NCT07132060 — MRI-guided Dose Intensification Program Locally Advanced Pancreatic Cancer · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05639374 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Clinica Universidad de Navarra, Universidad de Navarra
Last refreshed: 21 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05639374.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing